Sputnik over Europe
Sputnik over Europe

Author(s): Iwona Wiśniewska, Jadwiga Rogoża
Subject(s): Government/Political systems, Political behavior, Politics and communication, Comparative politics, Health and medicine and law, EU-Accession / EU-DEvelopment
Published by: OSW Ośrodek Studiów Wschodnich im. Marka Karpia
Keywords: Sputnik V; Europe; Western vaccines; disinformation; Production of the vaccine; COVID-19 pandemic;
Summary/Abstract: Since Sputnik V was registered in Russia in August 2020, a major global promotional campaign for the vaccine has been under way with the involvement of the state authorities, led by President Vladimir Putin. Recent weeks have seen the intensification of such a campaign in the European Union, which has been backed up by disinformation activities targeting Western vaccines. However, Sputnik V production levels have been low so far, and they do not meet the needs of either Russia or the countries that have signed up for it. Russian announcements that its production would soon begin outside the country, including in Europe, have also failed to come true. Available information shows that about a third of all Sputnik V doses delivered to the market are exported. However, an analysis of the contracts signed and the volume of deliveries made places Russia at the bottom of the global list of producers and suppliers. Like other manufacturers, it has to keep choosing who to send vaccines to first (and in what quantities). In effect, Europe and Latin America have been the priority destinations for shipments abroad, although even those contracts are not being fulfilled on time. Bulk quantities of Sputnik V are unlikely to arrive in Europe before autumn 2021.

• Details
• Contents